ARCHIVES

Obey Continue Crusade On Carcinogenesis, Attack On DCCP, Shubik

This article is from The Cancer Letter archive.

Vol. 03 No. 13 | April 1, 1977

Download PDF Visit The Full Archive

Related Articles

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk

January 23, 1981

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

January 28, 2011

DCT Advisors Okay PA In Imaging Patters Of Care RFA; Contracts

March 5, 1993

Funding Opportunities.

June 7, 2002

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014